Back to Search
Start Over
Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma.
- Source :
-
Virchows Archiv : an international journal of pathology [Virchows Arch] 2017 Jan; Vol. 470 (1), pp. 113-117. Date of Electronic Publication: 2016 Nov 25. - Publication Year :
- 2017
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Disease-Free Survival
Female
Humans
Lymphoma, Large B-Cell, Diffuse metabolism
Lymphoma, Large B-Cell, Diffuse pathology
Male
Middle Aged
Prognosis
Young Adult
Cytoplasm metabolism
Histocompatibility Antigens Class II immunology
Lymphoma, Large B-Cell, Diffuse diagnosis
Lymphoma, Large B-Cell, Diffuse immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1432-2307
- Volume :
- 470
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Virchows Archiv : an international journal of pathology
- Publication Type :
- Academic Journal
- Accession number :
- 27888357
- Full Text :
- https://doi.org/10.1007/s00428-016-2041-7